Get started
Live feed
PRReleasevia Quantisnow
Clearmind Medicine Inc. logo

Clearmind Medicine Announces 1-for-40 Reverse Share Split

ByQuantisnow··Wall Street's wire, on your screen.
Stocks in this Quantisnow insight

Historical context for CMND

Across the 17 sessions after earlier CMND headlines, the stock closed higher 3 times and lower 14 times, with a median move of 7.7% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.

CMND close-to-close change in the session after earlier headlines
SessionEarlier headlineCMNDSPY
Dec 8, 2025Clearmind Medicine Announces Receipt of Nasdaq Minimum Bid Price Notification-2.8%-0.3%
Dec 2, 2025Clearmind Medicine Advances CMND-100 to Dosing Phase at Hadassah Medical Center in Ongoing Phase I/IIa Clinical Trial for Alcohol Use Disorder-9.9%+0.2%
Dec 1, 2025Clearmind Medicine Charges Forward in Alcoholism Treatment: Positive Cohort Data, Full DSMB Approval, and New Elite Site Joins the Clinical Trial-6.9%-0.5%
Nov 25, 2025Clearmind Medicine Kicks-Off Patient Enrollment at Tel Aviv Sourasky Medical Center, Adding Another Site Activated in its in Phase I/IIa Alcohol Use Disorder Trial-19.4%+0.9%
Nov 24, 2025Clearmind Medicine's Data and Safety Monitoring Board Unanimously Approves Continuation of Phase I/IIa Clinical Trial for CMND-100 Following Positive Interim Safety Review+8.4%+1.5%
Nov 20, 2025Clearmind Medicine Accelerate FDA-Approved Alcohol Use Disorder Clinical Trial by Activating Fifth Elite Global Medical Site-1.8%-1.5%
Quantisnow market dataNASDAQ
Clearmind Medicine Inc. logo
CMND
Clearmind Medicine Inc.
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Get push alerts for CMND

Follow CMND and get a push notification the moment its next story breaks.

Full CMND profile on Quantisnow

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CMND (Clearmind Medicine Inc.) and more on Quantisnow.